These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33588697)

  • 1. Predictive value of novel biomarkers for chronic kidney disease among workers occupationally exposed to silica.
    Ramadan MA; Abdelgwad M; Fouad MM
    Toxicol Ind Health; 2021 Apr; 37(4):173-181. PubMed ID: 33588697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of Subclinical Early Nephrotoxicity Induced by Occupational Exposure to Silica among Workers in Pottery Industry.
    Mourad BH; Ashour YA
    Int J Occup Environ Med; 2020 Apr; 11(2):85-94. PubMed ID: 32218556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary L-FABP and anaemia: distinct roles of urinary markers in type 2 diabetes.
    von Eynatten M; Baumann M; Heemann U; Zdunek D; Hess G; Nawroth PP; Bierhaus A; Humpert PM
    Eur J Clin Invest; 2010 Feb; 40(2):95-102. PubMed ID: 19912308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction.
    Holzscheiter L; Beck C; Rutz S; Manuilova E; Domke I; Guder WG; Hofmann W
    Clin Chem Lab Med; 2014 Apr; 52(4):537-46. PubMed ID: 24243749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of Serum Creatinine and Kidney Injury Biomarkers for Diagnosing Histologic Acute Tubular Injury.
    Moledina DG; Hall IE; Thiessen-Philbrook H; Reese PP; Weng FL; Schröppel B; Doshi MD; Wilson FP; Coca SG; Parikh CR
    Am J Kidney Dis; 2017 Dec; 70(6):807-816. PubMed ID: 28844586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of contrast-induced acute kidney injury by early post-procedural analysis of urinary biomarkers and intra-renal Doppler flow indices in patients undergoing coronary angiography.
    Wybraniec MT; Chudek J; Bożentowicz-Wikarek M; Mizia-Stec K
    J Interv Cardiol; 2017 Oct; 30(5):465-472. PubMed ID: 28685874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
    Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary NGAL, KIM-1 and L-FABP concentrations in antenatal hydronephrosis.
    Noyan A; Parmaksiz G; Dursun H; Ezer SS; Anarat R; Cengiz N
    J Pediatr Urol; 2015 Oct; 11(5):249.e1-6. PubMed ID: 26096437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary KIM-1, NGAL and L-FABP for the diagnosis of AKI in patients with acute coronary syndrome or heart failure undergoing coronary angiography.
    Torregrosa I; Montoliu C; Urios A; Andrés-Costa MJ; Giménez-Garzó C; Juan I; Puchades MJ; Blasco ML; Carratalá A; Sanjuán R; Miguel A
    Heart Vessels; 2015 Nov; 30(6):703-11. PubMed ID: 24989970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary L-FABP predicts poor outcomes in critically ill patients with early acute kidney injury.
    Parr SK; Clark AJ; Bian A; Shintani AK; Wickersham NE; Ware LB; Ikizler TA; Siew ED
    Kidney Int; 2015 Mar; 87(3):640-8. PubMed ID: 25229339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of urinary tubular markers for monitoring chronic tubulointerstitial injury after ischemia-reperfusion.
    Ichikawa D; Kamijo-Ikemori A; Sugaya T; Ohata K; Hisamichi M; Hoshino S; Kimura K; Shibagaki Y
    Nephrology (Carlton); 2018 Apr; 23(4):308-316. PubMed ID: 28063188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-transplant Evaluation of Donor Urinary Biomarkers can Predict Reduced Graft Function After Deceased Donor Kidney Transplantation.
    Koo TY; Jeong JC; Lee Y; Ko KP; Lee KB; Lee S; Park SJ; Park JB; Han M; Lim HJ; Ahn C; Yang J
    Medicine (Baltimore); 2016 Mar; 95(11):e3076. PubMed ID: 26986138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of a urinary biomarker panel for obstructive nephropathy and clinical outcomes.
    Xie Y; Xue W; Shao X; Che X; Xu W; Ni Z; Mou S
    PLoS One; 2014; 9(11):e112865. PubMed ID: 25402279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Level of urinary liver-type fatty acid-binding protein is associated with cardiac markers and electrocardiographic abnormalities in type-2 diabetes with chronic kidney disease stage G1 and G2.
    Maeda Y; Suzuki A; Ishii J; Sekiguchi-Ueda S; Shibata M; Yoshino Y; Asano S; Hayakawa N; Nakamura K; Akiyama Y; Kitagawa F; Sakuishi T; Fujita T; Hashimoto S; Ozaki Y; Itoh M
    Heart Vessels; 2015 May; 30(3):362-8. PubMed ID: 24626813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of kidney dysfunction in non-silicotic Egyptian workers.
    Ibrahim KS; Ahmed SB; Amer NM
    Int J Hyg Environ Health; 2011 Jan; 214(1):53-8. PubMed ID: 20851677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery.
    Parikh CR; Thiessen-Philbrook H; Garg AX; Kadiyala D; Shlipak MG; Koyner JL; Edelstein CL; Devarajan P; Patel UD; Zappitelli M; Krawczeski CD; Passik CS; Coca SG;
    Clin J Am Soc Nephrol; 2013 Jul; 8(7):1079-88. PubMed ID: 23599408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary KIM-1: a novel biomarker for evaluation of occupational exposure to lead.
    Zhou R; Xu Y; Shen J; Han L; Chen X; Feng X; Kuang X
    Sci Rep; 2016 Dec; 6():38930. PubMed ID: 27966578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of urinary liver-type fatty acid-binding protein for the diagnosis of renal diseases in dogs.
    Takashima S; Nagamori Y; Ohata K; Oikawa T; Sugaya T; Kobatake Y; Nishii N
    J Vet Med Sci; 2021 Sep; 83(9):1465-1471. PubMed ID: 34526412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers for early detection of sickle nephropathy.
    Sundaram N; Bennett M; Wilhelm J; Kim MO; Atweh G; Devarajan P; Malik P
    Am J Hematol; 2011 Jul; 86(7):559-66. PubMed ID: 21630304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of urinary liver-type fatty acid-binding protein with renal functions and antihyperglycemic drug use in type 2 diabetic nephropathy patients.
    Hirowatari K; Kawano N
    Int Urol Nephrol; 2023 Aug; 55(8):2111-2118. PubMed ID: 36840803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.